Location: New York, NY
CIK: 0001263508 · Show all filings
Period: Q1 2020 (← Previous) (Next →)
Filing Date: May 15, 2020
Total Value: $16.24B (99.7% shares, 0.3% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | Seattle Genetics, Inc. | 50,060,240 | $5.776B | 35.6% | $37.84 | — | COM | 812578102 |
| INCY | Incyte Corporation | 31,978,785 | $2.342B | 14.4% | $73.07 | +3.4% | COM | 45337C102 |
| ACAD | ACADIA Pharmaceuticals Inc. | 41,904,586 | $1.77B | 10.9% | $18.86 | +118.5% | COM | 004225108 |
| ONC | BeiGene, Ltd. | 11,777,285 | $1.45B | 8.9% | $117.58 | — | SPONSORED ADR | 07725L102 |
| — | Alexion Pharmaceuticals, Inc. | 8,760,794 | $787M | 4.8% | $162.46 | — | COM | 015351109 |
| BMRN | BioMarin Pharmaceutical Inc. | 7,589,294 | $641M | 3.9% | $81.02 | +6.3% | COM | 09061G101 |
| KOD | Kodiak Sciences Inc. | 11,574,538 | $552M | 3.4% | $15.71 | +282.0% | COM | 50015M109 |
| ASND | Ascendis Pharma A/S | 3,390,270 | $382M | 2.4% | $44.21 | — | SPONSORED ADR | 04351P101 |
| — | IGM Biosciences, Inc. | 3,144,000 | $177M | 1.1% | $17.75 | — | COM | 449585108 |
| — | Amarin Corporation plc | 34,496,685 | $138M | 0.8% | $8.93 | — | SPONSORED ADR | 023111206 |
| ARGX | argenx SE | 1,019,557 | $134M | 0.8% | $59.75 | — | SPONSORED ADR | 04016X101 |
| — | Invitae Corporation | 9,100,615 | $124M | 0.8% | $17.07 | — | COM | 46185L103 |
| — | Principia Biopharma Inc. | 1,955,413 | $116M | 0.7% | $33.55 | — | COM | 74257L108 |
| — | Mirati Therapeutics, Inc. | 1,409,784 | $108M | 0.7% | $22.85 | — | COM | 60468T105 |
| NBIX | Neurocrine Biosciences, Inc. | 1,240,243 | $107M | 0.7% | $62.87 | +55.7% | COM | 64125C109 |
| EXAS | Exact Sciences Corporation | 1,846,139 | $107M | 0.7% | $87.91 | -7.7% | COM | 30063P105 |
| — | Ra Pharmaceuticals, Inc. | 2,093,839 | $101M | 0.6% | $24.19 | — | COM | 74933V108 |
| MDGL | Madrigal Pharmaceuticals, Inc. | 1,499,212 | $100M | 0.6% | $104.81 | -20.5% | COM | 558868105 |
| — | MyoKardia, Inc. | 1,774,234 | $83.18M | 0.5% | $52.95 | — | COM | 62857M105 |
| HRTX | Heron Therapeutics, Inc. | 6,018,104 | $70.65M | 0.4% | $17.78 | +5.7% | COM | 427746102 |
| CERS | Cerus Corporation | 13,713,195 | $63.77M | 0.4% | $4.64 | -2.4% | COM | 157085101 |
| — | Zymeworks Inc. | 1,708,472 | $60.6M | 0.4% | $14.76 | — | COM | 98985W102 |
| — | Tricida, Inc. | 2,666,015 | $58.65M | 0.4% | $29.10 | — | COM | 89610F101 |
| — | Atreca, Inc. | 3,532,760 | $58.47M | 0.4% | $18.84 | — | CL A COM | 04965G109 |
| — | DBV Technologies S.A. | 14,614,264 | $57.29M | 0.4% | $19.06 | — | SPONSORED ADR | 23306J101 |
| AXSM | Axsome Therapeutics, Inc. | 889,757 | $52.34M | 0.3% | $16.16 | +404.1% | COM | 05464T104 |
| INSM | Insmed Incorporated | 3,025,384 | $48.5M | 0.3% | $22.18 | +6.9% | COM PAR $.01 | 457669307 |
| — | Kiniksa Pharmaceuticals, Ltd. | 2,799,577 | $43.34M | 0.3% | $17.35 | — | COM CL A | G5269C101 |
| RYTM | Rhythm Pharmaceuticals, Inc. | 2,708,200 | $41.22M | 0.3% | $26.63 | -32.8% | COM | 76243J105 |
| KRYS | Krystal Biotech, Inc. | 946,471 | $40.92M | 0.3% | $22.57 | +131.7% | COM | 501147102 |
| — | Neurocrine Biosciences, Inc. | 30,770,000 | $39.32M | 0.2% | $1.24 | — | NOTE 2.25% 5/15/2024 | 64125CAD1 |
| — | Neoleukin Therapeutics, Inc. | 3,397,740 | $38.67M | 0.2% | $2.85 | — | COM | 64049K104 |
| — | ChemoCentryx, Inc. | 859,015 | $34.52M | 0.2% | $33.40 | — | COM | 16383L106 |
| — | Allakos Inc. | 735,469 | $32.72M | 0.2% | $60.26 | — | COM | 01671P100 |
| — | GW Pharmaceuticals plc | 370,845 | $32.48M | 0.2% | $132.99 | — | ADS | 36197T103 |
| AUPH | Aurinia Pharmaceuticals Inc. | 1,701,929 | $24.7M | 0.2% | $9.21 | +91.5% | COM | 05156V102 |
| — | Merus N.V. | 2,037,469 | $24.65M | 0.2% | $10.77 | — | COM | N5749R100 |
| APLS | Apellis Pharmaceuticals, Inc. | 896,551 | $24.02M | 0.1% | $28.57 | +24.3% | COM | 03753U106 |
| — | Assembly Biosciences, Inc. | 1,541,618 | $22.86M | 0.1% | $17.50 | — | COM | 045396108 |
| BCRX | BioCryst Pharmaceuticals, Inc. | 10,946,166 | $21.89M | 0.1% | $6.96 | -60.4% | COM | 09058V103 |
| — | Frequency Therapeutics, Inc. | 1,180,162 | $21.02M | 0.1% | $17.53 | — | COM | 35803L108 |
| ADPT | Adaptive Biotechnologies Corporation | 743,734 | $20.66M | 0.1% | $44.30 | -37.0% | COM | 00650F109 |
| ALKS | Alkermes plc | 1,244,744 | $17.95M | 0.1% | $24.20 | -26.2% | SHS | G01767105 |
| QURE | uniQure N.V. | 357,083 | $16.94M | 0.1% | $18.33 | +213.5% | SHS | N90064101 |
| — | BioMarin Pharmaceutical Inc. | 15,000,000 | $15.58M | 0.1% | $1.01 | — | NOTE 0.599% 8/1/2024 | 09061GAH4 |
| XNCR | Xencor, Inc. | 428,120 | $12.79M | 0.1% | $11.07 | +199.4% | COM | 98401F105 |
| URGN | UroGen Pharma Ltd. | 672,912 | $12.01M | 0.1% | $32.15 | -16.0% | COM | M96088105 |
| PTGX | Protagonist Therapeutics, Inc. | 1,679,164 | $11.86M | 0.1% | $9.61 | -22.1% | COM | 74366E102 |
| ADAPY | Adaptimmune Therapeutics plc | 3,690,307 | $10.04M | 0.1% | $2.72 | — | SPONSORED ADR | 00653A107 |
| — | Aimmune Therapeutics, Inc. | 673,908 | $9.718M | 0.1% | $16.20 | — | COM | 00900T107 |
| UROV | Urovant Sciences Ltd. | 1,000,000 | $9.22M | 0.1% | $15.51 | — | SHS | G9381B108 |
| MIRM | Mirum Pharmaceuticals, Inc. | 583,333 | $8.167M | 0.1% | $14.04 | +16.9% | COM | 604749101 |
| — | Reata Pharmaceuticals, Inc. | 55,983 | $8.081M | 0.0% | $188.33 | — | CL A | 75615P103 |
| — | Aeglea BioTherapeutics, Inc. | 1,713,604 | $7.985M | 0.0% | $5.64 | — | COM | 00773J103 |
| IFRX | Inflarx N.V. | 1,778,415 | $6.794M | 0.0% | $2.91 | +27.4% | COM | N44821101 |
| ALEC | Alector, Inc. | 280,000 | $6.756M | 0.0% | $25.49 | 0.0% | COM | 014442107 |
| SGMO | Sangamo Therapeutics, Inc. | 999,823 | $6.369M | 0.0% | $11.28 | -34.2% | COM | 800677106 |
| — | BioDelivery Sciences International, Inc. | 1,638,334 | $6.209M | 0.0% | $3.79 | — | COM | 09060J106 |
| FLGT | Fulgent Genetics, Inc. | 569,444 | $6.127M | 0.0% | $11.30 | +23.3% | COM | 359664109 |
| — | Idera Pharmaceuticals, Inc. | 4,608,786 | $6.084M | 0.0% | $1.32 | — | COM PAR | 45168K405 |
| — | Albireo Pharma, Inc. | 369,047 | $6.041M | 0.0% | $20.86 | — | COM | 01345P106 |
| — | Horizon Therapeutics Public Ltd Co | 200,000 | $5.924M | 0.0% | $29.62 | — | SHS | G46188101 |
| — | HOOKIPA Pharma Inc. | 700,481 | $5.779M | 0.0% | $6.73 | — | COM | 43906K100 |
| — | IVERIC bio, Inc. | 1,635,501 | $5.626M | 0.0% | $3.89 | — | COM | 46583P102 |
| CABA | Cabaletta Bio, Inc. | 636,363 | $4.645M | 0.0% | $11.85 | +15.7% | COM | 12674W109 |
| — | ArTara Therapeutics, Inc. | 199,671 | $4.592M | 0.0% | $23.00 | — | COM | 04300J107 |
| — | Millendo Therapeutics, Inc. | 833,333 | $4.4M | 0.0% | $6.74 | — | COM | 60040X103 |
| — | Passage Bio, Inc. | 275,000 | $4.331M | 0.0% | $15.75 | — | COM | 702712100 |
| — | Constellation Pharmaceuticals, Inc. | 133,333 | $4.191M | 0.0% | $6.73 | — | COM | 210373106 |
| — | Immunomedics, Inc. | 310,000 | $4.179M | 0.0% | $13.48 | — | COM | 452907108 |
| — | Minerva Neurosciences, Inc. | 688,531 | $4.145M | 0.0% | $6.02 | — | COM | 603380106 |
| — | Syros Pharmaceuticals, Inc. | 690,167 | $4.093M | 0.0% | $13.72 | — | COM | 87184Q107 |
| CPRX | Catalyst Pharmaceuticals, Inc. | 1,060,714 | $4.084M | 0.0% | $2.70 | +51.9% | COM | 14888U101 |
| — | Abeona Therapeutics Inc. | 1,590,686 | $3.34M | 0.0% | $5.53 | — | COM | 00289Y107 |
| ANAB | AnaptysBio, Inc. | 234,592 | $3.315M | 0.0% | $35.31 | -57.1% | COM | 032724106 |
| — | Evofem Biosciences, Inc. | 621,297 | $3.305M | 0.0% | $6.02 | — | COM | 30048L104 |
| — | Molecular Templates, Inc. | 237,917 | $3.162M | 0.0% | $7.45 | — | COM | 608550109 |
| — | NGM Biopharmaceuticals, Inc. | 250,000 | $3.083M | 0.0% | $14.64 | — | COM | 62921N105 |
| — | Orchard Therapeutics plc | 405,702 | $3.055M | 0.0% | $14.53 | — | ADS | 68570P101 |
| — | Karuna Therapeutics, Inc. | 41,976 | $3.022M | 0.0% | $71.99 | — | COM | 48576A100 |
| — | Aravive, Inc. | 486,333 | $2.801M | 0.0% | $5.03 | — | COM | 03890D108 |
| — | Marker Therapeutics, Inc. | 1,470,198 | $2.793M | 0.0% | $5.55 | — | COM | 57055L107 |
| CRNX | Crinetics Pharmaceuticals, Inc. | 175,000 | $2.573M | 0.0% | $27.18 | -24.6% | COM | 22663K107 |
| GLPG | Galapagos NV | 13,072 | $2.561M | 0.0% | $51.50 | — | SPONSORED ADR | 36315X101 |
| — | Acceleron Pharma Inc. | 27,000 | $2.426M | 0.0% | $89.85 | — | COM | 00434H108 |
| — | Global Blood Therapeutics, Inc. | 47,000 | $2.401M | 0.0% | $51.09 | — | COM | 37890U108 |
| — | Harpoon Therapeutics, Inc. | 204,467 | $2.368M | 0.0% | $9.47 | — | COM | 41358P106 |
| — | Matinas BioPharma Holdings, Inc. | 3,754,221 | $2.253M | 0.0% | $0.90 | — | COM | 576810105 |
| — | Applied Therapeutics, Inc. | 65,934 | $2.155M | 0.0% | $32.68 | — | COM | 03828A101 |
| VKTX | Viking Therapeutics, Inc. | 425,000 | $1.989M | 0.0% | $11.90 | -48.3% | COM | 92686J106 |
| — | bluebird bio, Inc. | 40,000 | $1.838M | 0.0% | $41.25 | — | COM | 09609G100 |
| DNLI | Denali Therapeutics Inc. | 104,900 | $1.837M | 0.0% | $20.86 | 0.0% | COM | 24823R105 |
| RCUS | Arcus Biosciences, Inc. | 121,534 | $1.687M | 0.0% | $15.69 | -20.7% | COM | 03969F109 |
| — | Menlo Therapeutics Inc. | 625,345 | $1.676M | 0.0% | $37.58 | — | COM | 586858102 |
| NTLA | Intellia Therapeutics, Inc. | 128,538 | $1.572M | 0.0% | $26.35 | -48.9% | COM | 45826J105 |
| — | Leap Therapeutics, Inc. | 978,454 | $1.546M | 0.0% | $1.17 | — | COM | 52187K101 |
| — | ARYA Sciences Acquisition Corp. | 150,000 | $1.527M | 0.0% | $10.18 | — | SHS CL A | G3165V109 |
| — | Dicerna Pharmaceuticals, Inc. | 81,935 | $1.505M | 0.0% | $18.37 | — | COM | 253031108 |
| — | Bellicum Pharmaceuticals, Inc. | 249,123 | $1.173M | 0.0% | $4.71 | — | COM | 079481404 |
| — | G1 Therapeutics, Inc. | 88,026 | $970K | 0.0% | $37.05 | — | COM | 3621LQ109 |
| AUTL | Autolus Therapeutics plc | 156,773 | $939K | 0.0% | $26.79 | — | SPON ADS | 05280R100 |
| — | Galmed Pharmaceuticals Ltd. | 215,594 | $746K | 0.0% | $11.90 | — | SHS | M47238106 |
| IDYA | IDEAYA Biosciences, Inc. | 126,611 | $522K | 0.0% | $10.88 | -34.9% | COM | 45166A102 |
| — | Adamas Pharmaceuticals, Inc. | 172,630 | $499K | 0.0% | $14.46 | — | COM | 00548A106 |
| INFIQ | Infinity Pharmaceuticals, Inc. | 580,400 | $486K | 0.0% | $1.54 | -24.5% | COM | 45665G303 |
| GNFTY | Genfit SA | 26,696 | $395K | 0.0% | $14.80 | — | ADS | 372279109 |
| — | Affimed N.V. | 200,000 | $316K | 0.0% | $6.30 | — | COM | N01045108 |
| — | Sunesis Pharmaceuticals, Inc. | 556,665 | $231K | 0.0% | $4.37 | — | COM PAR | 867328700 |
| OVID | Ovid Therapeutics Inc. | 69,471 | $207K | 0.0% | $3.37 | 0.0% | COM | 690469101 |
| CTMX | CytomX Therapeutics, Inc. | 20,000 | $153K | 0.0% | $14.78 | -52.8% | COM | 23284F105 |